[1]
K. Asanuma, “Argatroban more effectively inhibits the thrombin activity in synovial fluid than naturally occurring thrombin inhibitors”, Cell Mol Biol (Noisy-le-grand), vol. 62, no. 6, pp. 27–32, May 2016.